Cargando…
Evaluating the administration costs of biologic drugs: development of a cost algorithm
Biologic drugs, as with all other medical technologies, are subject to a number of regulatory, marketing, reimbursement (financing) and other demand-restricting hurdles applied by healthcare payers. One example is the routine use of cost-effectiveness analyses or health technology assessments to det...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883988/ https://www.ncbi.nlm.nih.gov/pubmed/26208926 http://dx.doi.org/10.1186/s13561-014-0026-2 |